Trulieve Cannabis (TCNNF) Cash from Financing Activities (2020 - 2026)

Trulieve Cannabis (TCNNF) recorded quarterly Cash from Financing Activities of $54.8 million in Q1 2026, up 121.47% quarter-over-quarter from -$255.4 million in Q4 2025, and up 1318.92% on a YoY basis from $3.9 million in Q1 2025.

Trulieve Cannabis (TCNNF) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Trulieve Cannabis' Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $54.8 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 1318.92% year-over-year to $54.8 million; the TTM figure through Mar 2026 stood at -$211.2 million (down 480.4% YoY), while the FY2025 annual figure was -$270.5 million, down 708.93% from the prior year.
  • Cash from Financing Activities was $54.8 million for Q1 2026 at Trulieve Cannabis, up from -$255.4 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $85.9 million in Q4 2022 to a low of -$255.4 million in Q4 2025.
  • Historically, Cash from Financing Activities has averaged -$14.5 million across 5 years, with a median of -$4.8 million in 2025.
  • The sharpest annual moves came in 2025 and 2026: Cash from Financing Activities sank 3917.49% in 2025, then soared 1318.92% in 2026.
  • A 5-year view of Cash from Financing Activities shows it stood at $85.9 million in 2022, then slumped by 233.94% to -$115.0 million in 2023, then jumped by 94.47% to -$6.4 million in 2024, then tumbled by 3917.49% to -$255.4 million in 2025, then soared by 121.47% to $54.8 million in 2026.
  • The last three Cash from Financing Activities figures came in at $54.8 million (Q1 2026), -$255.4 million (Q4 2025), and -$4.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 13.00 Mn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -1.48 Bn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn -86.10 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn -
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 1.47 Bn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn -11.62 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn -18.05 Mn
10 Trulieve Cannabis - - 170.08 Mn 54.83 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 54.83 Mn
Mar 31, 2026 54.83 Mn
Dec 31, 2025 -255.39 Mn
Dec 31, 2025 -255.39 Mn
Sep 30, 2025 -4.77 Mn
Sep 30, 2025 -4.77 Mn
Jun 30, 2025 -5.84 Mn
Jun 30, 2025 -5.84 Mn
Mar 31, 2025 -4.50 Mn
Mar 31, 2025 -4.50 Mn
Dec 31, 2024 -6.36 Mn
Dec 31, 2024 -6.36 Mn
Sep 30, 2024 -16.36 Mn
Sep 30, 2024 -16.36 Mn
Jun 30, 2024 -9.17 Mn
Jun 30, 2024 -9.17 Mn
Mar 31, 2024 -1.55 Mn
Mar 31, 2024 -1.55 Mn
Dec 31, 2023 -114.99 Mn
Dec 31, 2023 -114.99 Mn